Tag: CANDOR

KdD outperforms Kd in R/R MM also in participants with poor renal function

Presented By
Prof. Meletios Dimopoulos, University of Athens, Greece
Trial
Phase 3, CANDOR
Conference
ASH 2023
Type
Peer-reviewed article

7 February 2024 14:58

Adding daratumumab to carfilzomib/dexamethasone prolongs PFS and OS in R/R MM

Presented By
Prof. Saad Usmani, UNC-Chapel Hill School of Medicine, USA
Trial
Phase 3, CANDOR
Conference
ASH 2019
Type
Peer-reviewed article

5 March 2020 19:49
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com